These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10442759)

  • 41. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
    Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
    Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Botulinum toxin type A-induced "rebalancing" in bilateral vocal cord paralysis?].
    Ptok M; Schönweiler R
    HNO; 2001 Jul; 49(7):548-52. PubMed ID: 11486589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder.
    deSilva B; Crenshaw D; Matrka L; Forrest LA
    Laryngoscope; 2019 Apr; 129(4):808-811. PubMed ID: 30548857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
    Truong DD; Bhidayasiri R
    Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of vocal fold granuloma using botulinum toxin type A.
    Nasri S; Sercarz JA; McAlpin T; Berke GS
    Laryngoscope; 1995 Jun; 105(6):585-8. PubMed ID: 7769940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin for relief of bilateral abductor paralysis of the larynx: histologic study in an animal model.
    Cohen SR; Thompson JW; Camilon FS
    Ann Otol Rhinol Laryngol; 1989 Mar; 98(3):213-6. PubMed ID: 2923396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharyngeal paralysis due to botulinum toxin injection.
    Koay CE; Alun-Jones T
    J Laryngol Otol; 1989 Jul; 103(7):698-9. PubMed ID: 2760528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal vocal cord movement treated with botulinum toxin in patients with asthma resistant to optimised management.
    Baxter M; Uddin N; Raghav S; Leong P; Low K; Hamza K; Holmes PW; Hamilton G; Thyagarajan D; Lau K; Bardin PG
    Respirology; 2014 May; 19(4):531-7. PubMed ID: 24655302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of intralaryngeal muscle synkinesis on perception of voice handicap in patients with unilateral vocal fold paralysis.
    Lin RJ; Munin MC; Rosen CA; Smith LJ
    Laryngoscope; 2017 Jul; 127(7):1628-1632. PubMed ID: 28105659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Airway augmentation and maintenance through laryngeal chemodenervation in children with impaired vocal fold mobility.
    Smith ME; Park AH; Muntz HR; Gray SD
    Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):610-2. PubMed ID: 17576914
    [No Abstract]   [Full Text] [Related]  

  • 54. Anatomic considerations in botulinum toxin type A therapy for spasmodic dysphonia.
    Castellanos PF; Gates GA; Esselman G; Song F; Vannier MW; Kuo M
    Laryngoscope; 1994 Jun; 104(6 Pt 1):656-62. PubMed ID: 8196438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bilateral vocal cords paralysis in newborn].
    Schultz P; Charpiot A; Edrissi M; Fauvet F; Donato L; Debry C
    Ann Otolaryngol Chir Cervicofac; 2007 Jul; 124(3):103-9. PubMed ID: 17521600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
    Brin MF; Blitzer A; Stewart C
    Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
    [No Abstract]   [Full Text] [Related]  

  • 58. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
    Ford CN; Bless DM; Lowery JD
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arytenoid abduction for bilateral vocal fold immobility.
    Woodson G
    Curr Opin Otolaryngol Head Neck Surg; 2011 Dec; 19(6):428-33. PubMed ID: 22001662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anterior and posterior medialization (APM) thyroplasty.
    Hong KH; Kim JH; Kim HK
    Laryngoscope; 2001 Aug; 111(8):1406-12. PubMed ID: 11568577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.